• Latest Posts

Exeliom Biosciences closes €24M financing for lead candidate 

New osteoarthritis treatment for horses could work for humans

Scientists design new enzyme using Antarctic bacteria and computer calculations

FDA approves BioMarin gene therapy for hemophilia A

FDA gives Orphan Drug Designation to CellCentric multiple myeloma drug

AI program finds multiple influenza drug targets

ADVERTISEMENT

Vesalius Biocapital to invest €95M in life science companies 

Small particles will deliver TB drugs to the lungs in the future

New platform cuts time engineering and selecting genome editors

UCB myasthenia gravis drug given FDA approval 

Astraveus exits stealth to advance cell and gene therapy platform

ADVERTISEMENT